icon-    folder.gif   Conference Reports for NATAP  
 
  19th Conference on Retroviruses and
Opportunistic Infections
Seattle, WA March 5 - 8, 2012
Back grey_arrow_rt.gif
 
 
 
Safety, Tolerability, and PK of the HIV Integrase Inhibitor Dolutegravir Given Twice Daily with Rifampin - Results of a Phase 1 Study among Healthy Volunteers
 
 
  Reported by Jules Levin
CROI 2012 March 5-8 Seattle WA
 

CROI1.gif

CROI2.gif

CROI3.gif

CROI4.gif

CROI5.gif

CROI6.gif